MedPath

Adial Pharmaceuticals

Adial Pharmaceuticals logo
🇺🇸United States
Ownership
Public
Established
2010-01-01
Employees
7
Market Cap
-
Website
http://www.adialpharma.com
Introduction

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

© Copyright 2025. All Rights Reserved by MedPath